tm logo

Monitor this mark

View On USPTO

NEUPOGEN
Live/Registered
REGISTERED AND RENEWED

on 02 Jun 2020

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

73820719 filed on 05th Aug 1989

Registration Number

1597117 registered on 22nd May 1990

in the Principal Register

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine

Trademark Operations MS 28-5-A

One Amgen Center Drive

Thousand Oaks CA 91320-1799

Filing Basis

1. use application currently

Disclaimer

NO DATA

NEUPOGEN

PHARMACEUTICAL PREPARATIONS - NAMELY, RECOMBINANT-HUMAN GRANULOCYTE-CSF FOR USE IN STIMULATING WHITE BLOOD CELL [ PROTECTION ] * PRODUCTION *

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICAL PREPARATIONS - NAMELY, RECOMBINANT-HUMAN GRANULOCYTE-CSF FOR USE IN STIMULATING WHITE BLOOD CELL [ PROTECTION ] * PRODUCTION *

First Use Date in General

12th Aug 1988

First Use Date in Commerce

12th Aug 1988

Mark Details

Serial Number

No 73820719

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-1169-US-3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
29th Apr 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29th Apr 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
29th Apr 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29th Apr 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29th Apr 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Apr 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th Jun 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02th Jun 2020REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
02th Jun 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02th Jun 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL